
Dr. Kavitha Kothur, a paediatric neurologist, helped treat an eight-month-old baby in Sydney who became the first person globally to receive precision medicine for KCNT1-related catastrophic epilepsy.
The infant, Bohdi Higginson, suffered up to 74 seizures in a single day before receiving his first dose of the targeted treatment on April 21, with his final seizure occurring three days later.
Dr. Kothur, an alumna of Gandhi Medical College in Hyderabad, utilized the Sydney Children’s Hospitals Network’s Innovative Therapies Pathway to fast-track the assessment of the previously untested drug.